Omega Fund Management

Latest statistics and disclosures from Omega Fund Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are NUVB, BBOT, BBNX, BCAX, KMTS, and represent 79.31% of Omega Fund Management's stock portfolio.
  • Added to shares of these 1 stock: ENGN.
  • Reduced shares in these 5 stocks: BBNX (-$18M), KMTS (-$7.2M), NUVB (-$6.7M), UPB, ENGNW.
  • Sold out of its position in ENGNW.
  • Omega Fund Management was a net seller of stock by $-30M.
  • Omega Fund Management has $287M in assets under management (AUM), dropping by 28.85%.
  • Central Index Key (CIK): 0001637359

Tip: Access up to 7 years of quarterly data

Positions held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Omega Fund Management

Omega Fund Management holds 11 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Nuvation Bio Common Stock Class A (NUVB) 25.3 $72M -8% 8.1M 8.96
 View chart
BridgeBio Oncology Therapeutics Common Stock (BBOT) 14.4 $41M 3.3M 12.52
 View chart
Beta Bionics Common Stock (BBNX) 14.0 $40M -31% 1.3M 30.47
 View chart
Bicara Therapeutics Common Stock (BCAX) 12.9 $37M 2.2M 16.83
 View chart
Kestra Med Technologies Common Stock (KMTS) 12.7 $36M -16% 1.4M 26.52
 View chart
Upstream Bio Common Stock (UPB) 12.6 $36M -2% 1.3M 27.15
 View chart
enGene Holdings Common Stock (ENGN) 2.8 $7.9M +66% 876k 9.03
 View chart
Alumis Common Stock (ALMS) 2.2 $6.4M 653k 9.76
 View chart
Sana Biotechnology Common Stock (SANA) 1.2 $3.4M 844k 4.07
 View chart
ImageneBio Common Stock (IMA) 1.1 $3.1M 455k 6.90
 View chart
Replimune Group Common Stock (REPL) 0.8 $2.4M 249k 9.72
 View chart

Past Filings by Omega Fund Management

SEC 13F filings are viewable for Omega Fund Management going back to 2014

View all past filings